rivastigmine has been researched along with Basal Ganglia Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, N; Lanctôt, KL; Thompson, S | 1 |
| Simard, M; van Reekum, R | 1 |
| Barkhof, F; Lane, R; Scheltens, P; Staekenborg, SS; van der Flier, WM; van Straaten, EC | 1 |
2 review(s) available for rivastigmine and Basal Ganglia Diseases
| Article | Year |
|---|---|
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2004 |
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Cognition Disorders; Donepezil; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Tacrine | 2004 |
1 trial(s) available for rivastigmine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Topics: Aged; Aged, 80 and over; Aphasia; Basal Ganglia Diseases; Brain Infarction; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia, Vascular; Female; Gait Disorders, Neurologic; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Phenylcarbamates; Prevalence; Reflex, Abnormal; Rivastigmine; Thalamus | 2008 |